Annexin Pharmaceuticals AB (publ) (STO: ANNX)

ANNX Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21.15	19.14	26.34	18.07	1.29	6.38
Cash & Short-Term Investments	21.15	19.14	26.34	18.07	1.29	6.38
Cash Growth	7.26%	-27.32%	45.79%	1302.56%	-79.82%	-68.00%
Accounts Receivable	11.74	10.32	3.67	3.51	9.99	3.25
Other Receivables	-	1.23	2.92	1.14	2.67	2.71
Receivables	11.74	11.55	6.6	4.65	12.66	5.96
Prepaid Expenses	-	2.08	1.79	6.09	1.92	0.71
Other Current Assets	-	-0	-0	-	-	-
Total Current Assets	32.89	32.77	34.72	28.81	15.88	13.05
Property, Plant & Equipment	0.36	0.5	0.79	1.08	1.37	0.01
Long-Term Investments	-	-	0.09	-	-	-
Other Intangible Assets	18.51	0.44	0.54	0.64	0.73	0.83
Long-Term Deferred Charges	-	17.37	15.53	11.95	9.36	7.72
Other Long-Term Assets	-	0	-	1.35	1.23	1.36
Total Assets	51.76	51.07	51.66	43.82	28.57	22.98
Accounts Payable	-	2.21	2.47	1.84	2.69	1.3
Accrued Expenses	-	4.58	4.33	6.94	6.01	3.83
Current Portion of Long-Term Debt	-	-	-	0.86	0.86	0.86
Current Unearned Revenue	-	15.12	9.34	8.44	8.52	3.18
Other Current Liabilities	24.45	1.5	1.5	1.21	0.88	0.7
Total Current Liabilities	24.45	23.41	17.64	19.27	18.96	9.86
Long-Term Debt	-	-	-	-	0.86	1.71
Other Long-Term Liabilities	0	-0	-0	-	-	-
Total Liabilities	24.45	23.41	17.63	19.27	19.82	11.58
Common Stock	3.13	3.13	3.13	2.41	2.04	1.86
Additional Paid-In Capital	189.09	188.86	188.77	163.03	124.28	101.59
Retained Earnings	-164.9	17.37	15.53	11.95	8.74	6.92
Comprensive Income & Other	-	-181.69	-173.41	-152.83	-126.3	-98.96
Total Common Equity	27.31	27.67	34.03	24.55	8.76	11.4
Shareholders' Equity	27.31	27.67	34.03	24.55	8.76	11.4
Total Liabilities & Equity	51.76	51.07	51.66	43.82	28.57	22.98
Total Debt	-	-	-	0.86	1.71	2.57
Net Cash (Debt)	21.15	19.14	26.34	17.21	-0.43	3.81
Net Cash Growth	7.26%	-27.32%	53.05%	-	-	-77.51%
Net Cash Per Share	0.54	0.47	0.76	0.62	-0.02	0.16
Filing Date Shares Outstanding	39.15	39.15	39.15	30.11	25.51	23.19
Total Common Shares Outstanding	39.15	39.15	39.15	30.11	25.51	23.19
Working Capital	8.44	9.36	17.08	9.53	-3.09	3.19
Book Value Per Share	0.70	0.71	0.87	0.82	0.34	0.49
Tangible Book Value	8.8	27.23	33.49	23.92	8.02	10.57
Tangible Book Value Per Share	0.22	0.70	0.86	0.79	0.31	0.46
Machinery	-	1.65	1.65	1.66	1.66	0.22

Source: S&P Capital IQ. Standard template. Financial Sources.